Lectin-conjugated POROS beads were employed for HPLC. Glycopeptide standards served as positive and negative controls. MARS-14 depleted, trypsin-digested human plasma was chromatographed and flow-through (FT) and bound fractions collected for ESI-LC-MS/MS analyses. Glycopeptides were enriched in the bound fraction as compared to FT.
1) Prepare lectin-conjugated POROS columns
2) Packing the lectin-conjugated POROS beads into a PEEK column
3) Program the HPLC method
Time | Flow rate (μl/min) | % A | % B |
0:00 | 50 | 100 | 0 |
9:00 | 50 | 100 | 0 |
9:01 | 500 | 0 | 100 |
13:50 | 500 | 0 | 100 |
13:51 | 3000 | 100 | 0 |
19:50 | 3000 | 100 | 0 |
Fraction | Delay to collection from sample injection | Duration of collection (min) |
Flow-through | 2.8 | 4.1 |
Bound | 9 | 2.6 |
4) Prepare samples for HPLC
5) Perform chromatography
6) Desalt collected fractions
For each fraction use one 1 mL Waters Oasis HLB SPE cartridge as follows:
7) PNGase F-digestion
8) Zip Tip samples
9) Representative Results:
The POROS conjugation typically yields on-bead lectin concentrations in the range of 2 – 20 mg/mL. This is optimal for affinity chromatography.
Lectin chromatography of trypsin-digested MARS-depleted human plasma typically enriches glycopeptides in the bound fraction. As the glycopeptides are PNGase F-treated prior to LC-MS/MS, they are identified as peptides with the N-linked consensus sequence, NXS/T (where X is any residue but proline), in which the asparagine has been converted to an aspartic acid through the action of PNGase F. Peptides with these characteristics are considered to be deglycosylated peptides (or “deglycopeptides”). On average the flow-through (FT) fraction from AAL or SNA chromatography contains 2-4% deglycopeptides, whereas 30-50% of the peptides recovered in the bound fraction are deglycopeptides. Typically, using a QStar Elite, 1000-1300 peptides will be identified in the FT fraction, and 200-400 peptides will be identified in the bound fraction. Two or more distinct Invertase deglycopeptides should be observed in the FT fraction and two or more distinct lactoferrin deglycopeptides in the bound fraction (Table 1).
Table 1.
This protocol provides a quick method for isolating and identifying glycopeptides in a glycan-specific manner. As glycosylation varies extensively within an organism, particularly during development and pathogenesis, this technique may be applicable to address a wide variety of questions. In particular, we are using the method to selectively enrich glycopeptides that have been modified with cancer-associated epitopes as a first step towards biomarker discovery.
This work was supported by the Clinical Proteomic Technologies for Cancer initiative, 5U24CA126477-04.
Material Name | Type | Company | Catalogue Number | Comment |
---|---|---|---|---|
Human plasma | We make this in house | |||
Human lactoferrin | Sigma | L0520 | Trypsin-digest before use | |
Yeast invertase | Sigma | I0408 | Trypsin-digest before use | |
Oass HLB SPE cartridges | Waters | WAT094225 | 1 cc volume | |
ZipTip pipet tips | Fisher | ZTC1 8M0 96 | Millipore, C18 for 10 ml pipette | |
Tris | Fisher | BP154-1 | 99% | |
Ammonium bicarbonate | Sigma | A6141 | 99% | |
Calcium chloride | Sigma | C4901 | 96% | |
Magnesium chloride | Sigma | M8266 | 98% | |
Acetic acid | Sigma | 242853 | 99.7% | |
pH indicator paper | Fisher | M95903 | Range 0-14 | |
Acetonitrile | Fisher | A998 | 99.9% | |
Formic acid | Pierce | 28905 | 99% | |
Phosphate-buffered saline | Invitrogen | 14190-136 | Without calcium and magnesium | |
Sodium azide | Sigma | 71289 | 99.5% | |
PNGase F | New England Biolabs | P0705L | Glycerol-free | |
Vacuum-filter flasks | Fisher | SCGVU05RE | 0.2 mm pores | |
POROS-AL beads | Applied Biosystems | 1-6028-02 | ||
Aleuria aurantia lectin | Vector Laboratories | L-1390 | ||
Sambucus nigra agglutinin | Vector Laboratories | L-1300 | ||
Sodium cyanoborohydride | Sigma | 296945 | 5.0 M solution |